ISDA appreciates the IOSCO Task Force on Cross-Border Regulation’s engagement with the industry at meetings in Hong Kong on April 7, London on April 25 and Washington, DC on April 28, 2014. Further to discussions during those meetings, ISDA wishes to comment on a number of specific issues, and highlight how OTC derivatives markets have been affected by a lack of effective cross-border regulatory harmonization. OTC derivatives markets have historically been the most global in nature of all financial markets, and the absence of consistency in regulatory reform is having a direct impact on these markets as a result. This also affects other product areas and, more importantly, threatens the efficiency with which ‘real economy’ end-users can manage and transfer business risk to financial markets.
Documents (1) for IOSCO Task Force on Cross-Border Regulation invitation for industry submissions
Latest
ISDA Publishes ISDA SIMM® Methodology, Version 2.8+2506
ISDA has published the ISDA SIMM® Methodology, version 2.8+2506, which is effective from December 6, 2025. This version of the SIMM includes updates based on the calibration of the main delta risk weights and other parameters using data up to...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Why We Must Seize the Moment to Fix Reporting
From the retirement of LIBOR to the rollout of margin requirements for non-cleared derivatives, we’ve seen over the past decade how some of the thorniest challenges have been overcome through close collaboration between the industry and the public sector. We...
ISDA Launches RFQ for DRR Traceability Tool
ISDA has launched a request for quote (RFQ) for the development of a traceability tool for its Digital Regulatory Reporting (DRR) solution. The traceability tool is intended to provide enhanced transparency for users of the ISDA DRR by pinpointing why...